Vital-Imi
  • HOME
  • ABOUT
    • PARTNERS
    • WORK PACKAGES
      • Work Package 1
      • Work Package 2
      • Work Package 3
      • Work Package 4
      • Work Package 5
  • PUBLICATIONS
  • UPDATES
  • MENU
    • EVENTS
    • PARTNERS
    • NEWSLETTER
    • CONTACT
    • PRIVACY POLICY
    • LOGIN
  • Search
  • Menu Menu

PUBLICATIONS

All 15 /Publications 15

Effectiveness of educational interventions for healthcare workers on vaccination dialogue with older adults: a systematic review

Journal title

Pre-vaccination immunotypes reveal weak and robust antibody responders to influenza vaccination

Frailty prevalence in 42 European countries by age and gender: development of the SHARE Frailty Atlas for Europe

Identification of aging-associated immunotypes and immune stability as indicators of post-vaccination immune activation

Using qualitative research to develop an elaboration of the TIDieR checklist for interventions to enhance vaccination communication: short report

Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population

Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond

Exploratory Analysis of the Economically Justifiable Price of a Hypothetical RSV Vaccine for Older Adults in the Netherlands and the United Kingdom

Healthcare Workers’ Perceptions and Experiences of Communicating with People over 50 about Vaccination

European data sources for computing burden of (potential) vaccine-preventable diseases in ageing adults

Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program

Health Economics of Vaccines: From Current Practice to Future Perspectives

Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands

Consultations for Influenza-Like Illness in Primary Care in The Netherlands: A Regression Approach

Preventing Infectious Diseases for Healthy Ageing: The VITAL Public-Private Partnership Project

Page 1 of 212

Newsletter

Contact

You can contact us by sending us an email.

The VITAL project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806776. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Scroll to top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok